Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBIA:SW

3,656.25 CHF 75.46 2.11%

As of 11:42:00 ET on 03/30/2015.

Snapshot for Adamant Global Biotech (ADGLBIA)

Year To Date: +9.32% 3-Month: +11.54% 3-Year: +44.19% 52-Week Range: 2,071.19 - 4,015.18
1-Month: +1.53% 1-Year: +54.03% 5-Year: - Beta vs SMI: 1.20

Mutual Fund Chart for ADGLBIA

No chart data available.
  • ADGLBIA:SW 3,656.25
  • 1M
  • 1Y
Interactive ADGLBIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADGLBIA

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBIA

NAV (on 2015-03-30) 3,656.25
Assets (M) (on 2015-03-30) 167.86
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for ADGLBIA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBIA

Front Load 2.50
Back Load 1.00
Current Mgmt Fee 1.81
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for ADGLBIA

Filing Date: 11/28/2014
Name Position Value % of Total
Celgene Corp 145,000 15,883,346 10.288%
Amgen Inc 95,000 15,131,238 9.801%
Gilead Sciences Inc 140,000 13,532,165 8.765%
Biogen Inc 40,000 11,858,373 7.681%
Alexion Pharmaceuticals Inc 60,000 11,267,169 7.298%
Regeneron Pharmaceuticals Inc 21,000 8,419,362 5.454%
Vertex Pharmaceuticals Inc 73,000 8,291,149 5.371%
Mylan NV 140,000 7,905,903 5.121%
Illumina Inc 40,000 7,356,901 4.765%
Medivation Inc 65,000 7,257,901 4.701%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil